S100A12 and rheumatoid arthritis: We measured serum levels of S100A8, S100A9 heterocomplexes, S100A12 and sRAGE in a previously characterized cohort of established RA patients to identify their possible relationship to joint and vascular damage and risk factors in RA patients [19].